Abstract:Background: Enhanced hepatic expression of the fatty acid transporter Cd36 correlates with liver fat accumulation, hepatosteatosis, insulin resistance, and hyperinsulinemia. Results: Insulin increases hepatic Cd36 expression in a Pparγ-dependent manner. Conclusion: Hyperinsulinemia stimulates hepatic Cd36 expression, which correlates with the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia. Significance: Hyperinsulinemia contributes to the development of hepatosteatosis and insulin resistance. Hepatosteatosis is associated with the development of both hepatic insulin resistance and Type 2 diabetes. Hepatic expression of Cd36, a fatty acid transporter, is enhanced in obese and diabetic murine models and human nonalcoholic fatty liver disease, and thus it correlates with hyperinsulinemia, steatosis, and insulin resistance. Here, we have explored the effect of hyperinsulinemia on hepatic Cd36 expression, development of hepatosteatosis, insulin resistance, and dysglycemia. A 3-week sucrose-enriched diet was sufficient to provoke hyperinsulinemia, hepatosteatosis, hepatic insulin resistance, and dysglycemia in CBA/J mice. The development of hepatic steatosis and insulin resistance in CBA/J mice on a sucrose-enriched diet was paralleled by increased hepatic expression of the transcription factor Pparγ and its target gene Cd36 whereas that of genes implicated in lipogenesis, fatty acid oxidation, and VLDL secretion was unaltered. Additionally, we demonstrate that insulin, in a Pparγ-dependent manner, is sufficient to directly increase Cd36 expression in perfused livers and isolated hepatocytes. Mouse strains that display low insulin levels, i.e. C57BL6/J, and/or lack hepatic Pparγ, i.e. C3H/HeN, do not develop hepatic steatosis, insulin resistance, or dysglycemia on a sucrose-enriched diet, suggesting that elevated insulin levels, via enhanced CD36 expression, provoke fatty liver development that in turn leads to hepatic insulin resistance and dysglycemia. Thus, our data provide evidence for a direct role for hyperinsulinemia in stimulating hepatic Cd36 expression and thus the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia.

Down-regulation of Hepatic HNF4alpha Gene Expression During Hyperinsulinemia Via SREBPs.

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Hepatocyte Nuclear Factor 4α Regulates the Expression of Pancreatic β-Cell Genes Implicated in Glucose Metabolism and Nutrient-induced Insulin Secretion

Transcriptional Regulation of X-Box-binding Protein One (XBP1) by Hepatocyte Nuclear Factor 4α (HNF4Α) Is Vital to Beta-cell Function

Activation of the Insulin Gene Promoter through a Direct Effect of Hepatocyte Nuclear Factor 4α

Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance*

Reduction of Ptp1b by Rnai Upregulates the Activity of Insulin Controlled Fatty Acid Synthase Promoter

Insulin-Regulated Srebp-1c And Pck1 Mrna Expression In Primary Hepatocytes From Zucker Fatty But Not Lean Rats Is Affected By Feeding Conditions

Inhibition of Hepatocyte Nuclear Factor 1b Induces Hepatic Steatosis Through DPP4/NOX1-mediated Regulation of Superoxide.

Hepatitis B X-interacting protein promotes the formation of the insulin gene–transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells

HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes

Peroxisome Proliferator-Activated Receptor-Δ Induces Insulin-Induced Gene-1 and Suppresses Hepatic Lipogenesis in Obese Diabetic Mice

Novel Mechanisms of Regulation of the Expression and Transcriptional Activity of Hepatocyte Nuclear Factor 4Α

Pancreatic and Duodenal Homeobox Gene 1 (pdx1) Down-Regulates Hepatic Transcription Factor 1 Alpha (hnf1α) Expression During Reprogramming of Human Hepatic Cells into Insulin-Producing Cells.

HNF-4α Regulated Mir-122 Contributes to Development of Gluconeogenesis and Lipid Metabolism Disorders in Type 2 Diabetic Mice and in Palmitate-Treated HepG2 Cells

HBP1 Inhibits the Development of Type 2 Diabetes Mellitus Through Transcriptional Activation of the IGFBP1 Gene.

Mbnl1-mediated Alternative Splicing of Circmlxipl Regulates Rbbp6-involved ChREBP Turnover to Inhibit Lipotoxicity-Induced Β-Cell Damage

Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis

Coordinated Regulation by Shp2 Tyrosine Phosphatase of Signaling Events Controlling Insulin Biosynthesis in Β‐cells

Peroxisome proliferator-activated receptor β / δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation

The MODY1 Gene for Hepatocyte Nuclear Factor 4α and a Feedback Loop Control COUP-TFII Expression in Pancreatic Beta Cells